Projects per year
Personal profile
Biography
Mark Cooper AO is Professor of Diabetes and head of the Department of Diabetes within the Central Clinical School. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.
Biography
Links:
- Department of Diabetes: www.med.monash.edu.au/cecs/diabetes/
- Professor Mark Cooper: www.med.monash.edu.au/cecs/diabetes/staff/cooper-mark.html
Research area keywords
- Diabetes
- Diabetic Complications
- kidney disease
- heart disease
- blindness
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
-
Reducing the burden of chronic kidney disease in the indigenous population - the PROPHECY CKD study
Cooper, M., Morey, K., Zimmet, P., Mentha, R., Jandeleit-Dahm, K., El-Osta, S., McDonald, S. P. & Khurana, I.
1/06/20 → 31/05/23
Project: Research
-
-
-
Targeting epigenetic pathways that lead to diabetic complications
Cooper, M., El-Osta, S., Jandeleit-Dahm, K., Quaggin, S. & Khurana, I.
1/01/18 → 31/12/21
Project: Research
-
The Meydan Family Foundation Diabetes Complications Research Hub
Cooper, M., Jane, S. & Mitchell, C.
31/12/16 → 31/12/25
Project: Research
Research output
-
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes
Sathish, T., Tapp, R. J., Cooper, M. E. & Zimmet, P., Mar 2021, In : Diabetes and Metabolism. 47, 2, 3 p., 101204.Research output: Contribution to journal › Editorial › Other › peer-review
Open Access3 Citations (Scopus) -
Processed foods drive intestinal barrier permeability and microvascular diseases
Snelson, M., Tan, S. M., Clarke, R. E., de Pasquale, C., Thallas-Bonke, V., Nguyen, T-V., Penfold, S. A., Harcourt, B. E., Sourris, K. C., Lindblom, R. S. J., Ziemann, M., Steer, D., El-Osta, A., Davies, M. J., Donnellan, L., Deo, P., Kellow, N. J., Cooper, M. E., Woodruff, T. M., Mackay, C. R. & 2 others, , 31 Mar 2021, In : Science Advances. 7, 14, 15 p., eabe4841.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial
Kim, H., Wang, D., Chalmers, J., Jun, M., Zoungas, S., Marre, M., Hamet, P., Harrap, S., Mancia, G., Poulter, N. R., Cooper, M. E., Woodward, M., Selvin, E. & Rebholz, C. M., Dec 2020, In : Journal of Diabetes. 12, 12, p. 929-941 13 p.Research output: Contribution to journal › Article › Research › peer-review
-
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Reutens, A. T., Jandeleit-Dahm, K., Thomas, M., Salim, A., De Livera, A. M., Bach, L. A., Colman, P. G., Davis, T. M. E., Ekinci, E. I., Fulcher, G., Hamblin, P. S., Kotowicz, M. A., MacIsaac, R. J., Morbey, C., Simmons, D., Soldatos, G., Wittert, G., Wu, T., Cooper, M. E. & Shaw, J. E., Mar 2020, In : Contemporary Clinical Trials. 90, 8 p., 105892.Research output: Contribution to journal › Article › Other › peer-review
6 Citations (Scopus) -
Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial
Cooper, M. E., Rosenstock, J., Kadowaki, T., Seino, Y., Wanner, C., Schnaidt, S., Clark, D., Johansen, O. E. & on behalf of the CARMELINA investigators, 1 Feb 2020, (Accepted/In press) In : Diabetes, Obesity and Metabolism. 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile4 Citations (Scopus)